Machine learning-based multiparametric traditional multislice computed tomography radiomics for improving the discrimination of parotid neoplasms.

computed tomography linear discriminant analysis machine learning parotid tumor radiomics

Journal

Molecular and clinical oncology
ISSN: 2049-9469
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 19 02 2021
accepted: 28 07 2021
entrez: 15 10 2021
pubmed: 16 10 2021
medline: 16 10 2021
Statut: ppublish

Résumé

Characterization of parotid tumors is important for treatment planning and prognosis, and parotid tumor discrimination has recently been developed at the molecular level. The aim of the present study was to establish a machine learning (ML) predictive model based on multiparametric traditional multislice CT (MSCT) radiomic and clinical data analysis to improve the accuracy of differentiation among pleomorphic adenoma (PA), Warthin tumor (WT) and parotid carcinoma (PCa). A total of 345 patients (200 with WT, 91 with PA and 54 with PCa) with pathologically confirmed parotid tumors were retrospectively enrolled from five independent institutions between January 2010 and May 2019. A total of 273 patients recruited from institutions 1, 2 and 3 were randomly assigned to the training model; the independent validation set consisted of 72 patients treated at institutions 1, 4 and 5. Data were investigated using a linear discriminant analysis-based ML classifier. Feature selection and dimension reduction were conducted using reproducibility testing and a wrapper method. The diagnostic accuracy of the predictive model was compared with histopathological findings as reference results. This classifier achieved a satisfactory performance for the discrimination of PA, WT and PCa, with a total accuracy of 82.1% in the training cohort and 80.5% in the validation cohort. In conclusion, ML-based multiparametric traditional MSCT radiomics can improve the accuracy of differentiation among PA, WT and PCa. The findings of the present study should be validated by multicenter prospective studies using completely independent external data.

Identifiants

pubmed: 34650812
doi: 10.3892/mco.2021.2407
pii: MCO-0-0-02407
pmc: PMC8506566
doi:

Types de publication

Journal Article

Langues

eng

Pagination

245

Informations de copyright

Copyright © 2020, Spandidos Publications.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

EBioMedicine. 2019 Dec;50:156-165
pubmed: 31735556
J Neuroeng Rehabil. 2017 Aug 14;14(1):82
pubmed: 28807038
Neuroradiology. 2014 Sep;56(9):789-95
pubmed: 24948426
J Comput Assist Tomogr. 2017 Jan;41(1):131-136
pubmed: 27636248
Front Oncol. 2019 Nov 05;9:1164
pubmed: 31750250
Br J Radiol. 2016;89(1060):20150912
pubmed: 26892378
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Clin Transl Med. 2020 Jun;10(2):e115
pubmed: 32602615
World J Radiol. 2013 Aug 28;5(8):313-20
pubmed: 24003357
Yonago Acta Med. 2018 Mar 28;61(1):33-39
pubmed: 29599620
J Oncol. 2019 Oct 31;2019:6328329
pubmed: 31781216
Int J Comput Assist Radiol Surg. 2019 Nov;14(11):1837-1845
pubmed: 31129859
Dentomaxillofac Radiol. 2018 Jul;47(5):20170343
pubmed: 29412748
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2228-2234
pubmed: 31372671
Eur J Radiol. 2018 Jun;103:51-56
pubmed: 29803385
Eur Radiol. 2011 Aug;21(8):1692-8
pubmed: 21547526

Auteurs

Zhifeng Xu (Z)

Department of Radiology, The First People's Hospital of Foshan, Foshan, Guangdong 528000, P.R. China.

Yabin Jin (Y)

Clinical Research Institute, The First People's Hospital of Foshan, Foshan, Guangdong 528000, P.R. China.

Wenxiu Wu (W)

Department of Radiology, The First People's Hospital of Foshan, Foshan, Guangdong 528000, P.R. China.

Jinmian Wu (J)

Department of Radiology, The Sanshui People's Hospital, Foshan, Guangdong 528100, P.R. China.

Bing Luo (B)

Department of Radiology, The First People's Hospital of Foshan, Foshan, Guangdong 528000, P.R. China.

Chenglong Zeng (C)

Department of Radiology, The First People's Hospital of Foshan, Foshan, Guangdong 528000, P.R. China.

Xiuqin Guo (X)

Department of Radiology, The Foshan Chancheng District Central Hospital, Foshan, Guangdong 528000, P.R. China.

Mingcong Gao (M)

Department of Radiology, The Foshan Medicine Hospital, Guangdong 528000, P.R. China.

Shiqin Guo (S)

Department of Radiology, The Second People's Hospital of Nanhai District, Foshan, Guangdong 528000, P.R. China.

Aizhen Pan (A)

Department of Radiology, The First People's Hospital of Foshan, Foshan, Guangdong 528000, P.R. China.

Classifications MeSH